Affiliation:
1. Neurology Unit, Department of Medical, Surgical and Experimental Sciences University of Sassari Sassari Italy
2. Neurology Unit, Department of Neuroscience, Biomedicine and Movement Sciences University of Verona Verona Italy
3. Department of Clinical Neurological Sciences Western University London Ontario Canada
4. Department of Neurology Mayo Clinic Rochester Minnesota USA
5. Department of Laboratory Medicine and Pathology Mayo Clinic Rochester Minnesota USA
6. Department of Neurology Mayo Clinic Jacksonville Florida USA
Abstract
AbstractBackgroundDifferentiating neuromyelitis optica spectrum disorder (NMOSD) from its mimics is crucial to avoid misdiagnosis, especially in the absence of aquaporin‐4‐IgG. While multiple sclerosis (MS) and myelin oligodendrocyte glycoprotein‐IgG associated disease (MOGAD) represent major and well‐defined differential diagnoses, non‐demyelinating NMOSD mimics remain poorly characterized.MethodsWe conducted a systematic review on PubMed/MEDLINE to identify reports of patients with non‐demyelinating disorders that mimicked or were misdiagnosed as NMOSD. Three novel cases seen at the authors' institutions were also included. The characteristics of NMOSD mimics were analyzed and red flags associated with misdiagnosis identified.ResultsA total of 68 patients were included; 35 (52%) were female. Median age at symptoms onset was 44 (range, 1–78) years. Fifty‐six (82%) patients did not fulfil the 2015 NMOSD diagnostic criteria. The clinical syndromes misinterpreted for NMOSD were myelopathy (41%), myelopathy + optic neuropathy (41%), optic neuropathy (6%), or other (12%). Alternative etiologies included genetic/metabolic disorders, neoplasms, infections, vascular disorders, spondylosis, and other immune‐mediated disorders. Common red flags associated with misdiagnosis were lack of cerebrospinal fluid (CSF) pleocytosis (57%), lack of response to immunotherapy (55%), progressive disease course (54%), and lack of magnetic resonance imaging gadolinium enhancement (31%). Aquaporin‐4‐IgG positivity was detected in five patients by enzyme‐linked immunosorbent assay (n = 2), cell‐based assay (n = 2: serum, 1; CSF, 1), and non‐specified assay (n = 1).ConclusionsThe spectrum of NMOSD mimics is broad. Misdiagnosis frequently results from incorrect application of diagnostic criteria, in patients with multiple identifiable red flags. False aquaporin‐4‐IgG positivity, generally from nonspecific testing assays, may rarely contribute to misdiagnosis.
Subject
Neurology (clinical),Neurology
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. NMOSD and MOGAD;CONTINUUM: Lifelong Learning in Neurology;2024-08
2. Epidemiology of aquaporin-4-IgG-positive NMOSD in Sardinia;Multiple Sclerosis and Related Disorders;2024-05